Mingyi Zhudao Secures $5 Million Angel Investment from ZhenFund Led by Xu Xiaoping

[Today's Highlights]

○ “Mingyi Zhudao” Secures RMB 5 Million in Angel Investment from Xu Xiaoping’s ZhenFund
○ Garmin's fitness segment achieves a 5% year-over-year growth
○ The “Guoyu Pharmaceutical Online” B2B website will officially launch on August 31
○ Dingdang Kuaiyao has achieved coverage in ten cities and plans to expand to six more

1. “Mingyi Zhudao” Secures RMB 5 Million in Angel Investment from Xu Xiaoping’s ZhenFund

Currently, most internet healthcare companies operate on B2B or B2C models, whereas “Mingyi Zhudao” is essentially a C2C model. Specifically, “Mingyi Zhudao” serves solely as a platform facilitating connections and services among patients, doctors, and hospitals, without charging any fees to either medical providers or patients. It was precisely this concept that enabled Su Shu, the founder of “Mingyi Zhudao,” to impress Xu Xiaoping, founder of ZhenFund, with a single phone call, securing an investment of RMB 5 million.



Su Shu aims to leverage the Internet to create a mobile surgical O2O platform, using patients’ surgical needs as an entry point and optimizing the allocation of medical resources through a straightforward C2C model. After completing their hospital duties, doctors can serve patients on the platform during their spare time.

As of July this year, “Mingyi Zhudao” has signed strategic cooperation agreements with thousands of experts at the level of associate chief physician or above from Grade A tertiary hospitals in cities such as Beijing, Shanghai, and Jiangsu. These experts include prominent domestic medical leaders such as Wang Xuehao, an academician of the Chinese Academy of Engineering and a leading authority in hepatobiliary surgery; Zhu Siquan, Director at Beijing Tongren Hospital and a specialist in cataracts; and Liu Yuewu, Director of the Department of General Surgery at Peking Union Medical College Hospital and a specialist in thyroid diseases. Su Yue stated that in cities where the platform has already established a presence, including Beijing, Shanghai, Hangzhou, and Nanjing, approximately 1,000 hospital beds are available daily for patients.

In addition, “Mingyi Zhudao” has reached a strategic cooperation intention with “Didi Chuxing” to jointly create the concept of “Didi Mingyi,” organically integrating services from renowned medical experts with Didi’s premium ride-hailing service to better serve patients.

2. Garmin's fitness sector achieves a 5% year-over-year growth rate annually

Since 2003, Garmin has been operating in the wearables business. However, in the highly competitive consumer fitness tracker market, the company launched only two products—vivosmart and vivofit—with less than a year between their releases. According to the company’s estimates, it captured only 10% to 15% of the market during that period. Its fitness segment grew at a year-over-year rate of 5%.


During the second-quarter earnings conference call, CEO and President Cliff Pemble discussed the company’s sluggish growth and formidable competitors with investors. Although Pemble did not mention it by name, it was clearly referring to Fitbit. In June, Fitbit’s IPO broke records, raising $732 million.

Pemble attributed the company’s sluggish growth in the second quarter to a confluence of factors, including adverse foreign exchange markets, competitive pricing pressures, and the absence of new product launches during the period. Lower profits this quarter were driven by substantial investments in advertising and research and development (R&D), aimed at securing the company’s long-term growth.

3. “Guoyu Pharmaceutical Online” B2B Website to Officially Launch on August 31
On July 28, “Guoyu Pharmaceutical Online” announced its plan to build an “Internet +” wholesale and procurement platform for the pharmaceutical and broader health industry, with its B2B website scheduled to officially launch on August 31.


According to Zhang Xiaoyang, CEO of “Guoyu Pharmaceutical Online,” the platform serves as a third-party marketplace for upstream suppliers and downstream purchasers. It aims to leverage internet-based solutions to enable buyers to complete precise procurement quickly, streamline purchasing processes, and reduce costs, ultimately passing the savings on to consumers.

“Guoyu Pharmaceutical Online” provides customers with diversified financial solutions, a self-developed electronic payment system, professional pharmaceutical logistics, and online bidding procurement services. Furthermore, it leverages cloud data processing to automatically and precisely match purchasers’ demands with supplier resources, delivering tailored procurement solutions for buyers.

4. Dingdang Kuaiyao Has Completed Coverage in Ten Cities and Plans to Expand to Six More
Since its launch, Dingdang Kuaiyao has experienced rapid growth and is actively expanding its presence across China. It is reported that Dingdang Kuaiyao has already established operations in 10 cities, including Beijing, Guangzhou, Hangzhou, Chengdu, Tianjin, Shenzhen, Xi’an, Suzhou, Zhengzhou, and Nanchang, and will further extend its coverage to six additional cities: Shanghai, Chongqing, Nanjing, Jinan, Wuhan, and Shenyang. The company expects to achieve comprehensive coverage of key provincial capital cities nationwide by September 28.


On July 11, Dingdang Kuaiyao announced a partnership with Meituan Waimai to add a pharmaceutical section to the Meituan Waimai platform. According to insiders, Dingdang Kuaiyao will also collaborate with Baidu Waimai to jointly expand its market across China.

A relevant executive at Dingdang Kuaiyao stated that the smooth progress of its nationwide market expansion strategy is primarily attributable to Renhe Group’s industrial chain resources, Dingdang Kuaiyao’s FSC Pharmacy Alliance, and its highly capable offline team.